Yidan Biotech
Retatrutide
Finnrick tested 6 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Yidan Biotech between 26 Jan 2026 and 30 Jul 2026. Test scores average over 7, no score below 6, and at least 6 tests warrant a confident Finnrick Rating of A (Great).
Finnrick Rating™
Yidan Biotech
Retatrutide
Tested 6 Samples
Last test 30 Jul 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Yidan Biotech
Samples are tested in commercial labs
Tests Count
6
Scores
AVGMINMAX
Last
30 Jul 2026
First
26 Jan 2026
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 30 Jul 2026 | View | 15mg | 15.4mg | +2.7% | 99.80% | n/a | Mfg: April 22, 2026 | No label, Copper crimp, Clear cap | Lab G | Public | |
| 17 Jul 2026 | View | 30mg | 27.2mg | -9.3% | 99.90% | n/a | RT30-2026-0527 | No label / Silver crimp / Red cap | Lab E | Public | |
| 12 Jun 2026 | View | 30mg | 27.7mg | -7.7% | 99.70% | n/a | April 21, 2026 | No label / Silver crimp / Clear Pink cap | Lab G | Public | |
| 6 May 2026 | View | 20mg | 19mg | -5.0% | 99.90% | n/a | RT20-2026-0310 | No Label / Copper Crimp / Clear Cap | Lab E | Public | |
| 2 Mar 2026 | View | 30mg | 28.8mg | -4.0% | 98.01% | below LOQ | RT30-2026-116 | No Label / Silver Crimp / Black Cap | Lab E | Public | |
| 26 Jan 2026 | View | 10mg | 10.2mg | +2.0% | 99.80% | n/a | CO122025 Green Cap | White Label / Silver Crimp / Green Cap | Lab G | Public | |